2010
Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users
Paintsil E, He H, Peters C, Lindenbach BD, Heimer R. Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users. The Journal Of Infectious Diseases 2010, 202: 984-990. PMID: 20726768, PMCID: PMC2932767, DOI: 10.1086/656212.Peer-Reviewed Original ResearchConceptsHepatitis C virusInjection drug usersDrug usersC virusHigh prevalenceInsulin syringesViable virusTuberculin syringesHCV infectivityResidual volumeReporter virusDay 1Prevention strategiesDay 7Microculture assayDay 63VirusLuciferase activitySyringesDegrees CPrevalenceVirus survivalSurvivalVirus decay ratesDaysDrug Network Characteristics and HIV Risk Among Injection Drug Users in Russia: The roles of Trust, Size, and Stability
Cepeda JA, Odinokova VA, Heimer R, Grau LE, Lyubimova A, Safiullina L, Levina OS, Niccolai LM. Drug Network Characteristics and HIV Risk Among Injection Drug Users in Russia: The roles of Trust, Size, and Stability. AIDS And Behavior 2010, 15: 1003-1010. PMID: 20872063, PMCID: PMC3112286, DOI: 10.1007/s10461-010-9816-7.Peer-Reviewed Original Research
2001
Can HIV-1-Contaminated Syringes Be Disinfected?
Abdala N, Gleghorn A, Carney J, Heimer R. Can HIV-1-Contaminated Syringes Be Disinfected? JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 28: 487-494. DOI: 10.1097/00126334-200112150-00013.Peer-Reviewed Original ResearchCan HIV-1-Contaminated Syringes Be Disinfected?: Implications for Transmission Among Injection Drug Users.
Abdala N, Gleghorn A, Carney J, Heimer R. Can HIV-1-Contaminated Syringes Be Disinfected?: Implications for Transmission Among Injection Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 28: 487. PMID: 11744839, DOI: 10.1097/00042560-200112150-00013.Peer-Reviewed Original ResearchConceptsInjection drug usersHIV-1Undiluted bleachDrug usersHIV-1 recoveryViable HIV-1HIV-1 transmissionHarm reduction interventionsEffectiveness of bleachNeedle exchangeReduction interventionsMicroculture assaySingle rinseSterile syringeSyringesInjection behaviorEducational programsMinimal contact time
2000
Viability of HIV-1 in syringes: implications for interventions among injection drug users.
Heimer R, Abdala N. Viability of HIV-1 in syringes: implications for interventions among injection drug users. The AIDS Reader 2000, 10: 410-7. PMID: 10932845.Peer-Reviewed Original ResearchSurvival of HIV-1 in Syringes: Effects of Temperature during Storage
Abdala N, Reyes R, Carney J, Heimer R. Survival of HIV-1 in Syringes: Effects of Temperature during Storage. Substance Use & Misuse 2000, 35: 1369-1383. PMID: 10921429, DOI: 10.3109/10826080009148220.Peer-Reviewed Original Research
1999
Survival of HIV-1 in Syringes
Abdala N, Stephens C, Griffith B, Heimer R. Survival of HIV-1 in Syringes. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1999, 20: 73-80. PMID: 9928733, DOI: 10.1097/00042560-199901010-00011.Peer-Reviewed Original Research
1998
Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection
Rich J, Dickinson B, Carney J, Fisher A, Heimer R. Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection. AIDS 1998, 12: 2345-2350. PMID: 9863878, DOI: 10.1097/00002030-199817000-00017.Peer-Reviewed Original ResearchCan Syringe Exchange Serve as a Conduit to Substance Abuse Treatment?
Heimer R. Can Syringe Exchange Serve as a Conduit to Substance Abuse Treatment? Journal Of Substance Use And Addiction Treatment 1998, 15: 183-191. PMID: 9633030, DOI: 10.1016/s0740-5472(97)00220-1.Peer-Reviewed Original ResearchSyringe Use and Reuse: Effects of Syringe Exchange Programs in Four Cities
Heimer R, Khoshnood K, Bigg D, Guydish J, Junge B. Syringe Use and Reuse: Effects of Syringe Exchange Programs in Four Cities. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: s37-s44. PMID: 9663622, DOI: 10.1097/00042560-199802001-00008.Peer-Reviewed Original Research
1993
Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut
Heimer R, Kaplan E, Khoshnood K, Jariwala B, Cadman E. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. The American Journal Of Medicine 1993, 95: 214-220. PMID: 8356986, DOI: 10.1016/0002-9343(93)90263-o.Peer-Reviewed Original ResearchConceptsHIV-1 proviral DNANeedle exchange programsProviral DNANew Haven's needle exchange programNeedle exchangeHIV-1 prevalenceIntravenous drug usersNeedle exchange clientsDrug treatment programsPercentage of syringesDrug use habitsSyringe trackingDNA prevalenceNew HavenPolymerase chain reactionDrug treatmentDrug usersTreatment programPrevalenceChain reactionExchange programsSyringesMonthsProgram participantsFunded evaluation